Skip to content
Screener

Vivani Medical VANI Q3 2026 earnings

Reported November 12, 2026 · After market close

EPS-$0.08Beat by $0.01
EPS estimate-$0.09
“The third quarter and recent weeks mark a period of strong progress and forward momentum for Vivani. The top-line SLIM-1 results will be announced this week. We look forward to sharing those results with shareholders, industry peers, and the broader community of physicians and patients seeking less frequent dosing and the promise of potential improvements in convenience, medication adherence, and tolerability associated with GLP-1 therapies on the market and in clinical-stage development.”
Adam Mendelsohn

Next report

Date not yet announced

FAQ

When did Vivani Medical report Q3 2026 earnings?
Vivani Medical (VANI) reported Q3 2026 earnings on November 12, 2026 after market close.
What were Vivani Medical's Q3 2026 revenue and EPS?
Vivani Medical reported eps of $-0.08 for Q3 2026.
Did Vivani Medical beat estimates in Q3 2026?
EPS beat the consensus estimate of $-0.09 by $0.01.
How did Vivani Medical's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 27.3% from $-0.11.
Where can I find Vivani Medical's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001753926-26-002108) and the 10-Q periodic report (0001753926-26-002106) directly on SEC EDGAR. The filing index links above go to sec.gov.